Literature DB >> 3905978

Antibiotic resistance in developing countries.

W E Farrar.   

Abstract

Mesh:

Substances:

Year:  1985        PMID: 3905978     DOI: 10.1093/infdis/152.6.1103

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  21 in total

1.  Occurrence of multiple antibiotic resistance and R plasmids in Enterobacteriaceae isolated from children in the Sudan.

Authors:  P Shears; G Suliman; C A Hart
Journal:  Epidemiol Infect       Date:  1988-02       Impact factor: 2.451

2.  Evolution of Salmonella nomenclature: a critical note.

Authors:  M Agbaje; R H Begum; M A Oyekunle; O E Ojo; O T Adenubi
Journal:  Folia Microbiol (Praha)       Date:  2011-11-04       Impact factor: 2.099

3.  Differences in antimicrobial susceptibilities of clinical isolates in Saudi Arabia and the United States.

Authors:  S M Qadri; S Ostrawski; S Johnson; D J Flournoy
Journal:  J Natl Med Assoc       Date:  1987-04       Impact factor: 1.798

4.  Does chloramphenicol remain the drug of choice for typhoid?

Authors:  B Rowe; E J Threlfall; L R Ward
Journal:  Epidemiol Infect       Date:  1987-06       Impact factor: 2.451

Review 5.  Is antimicrobial resistance in hospital microorganisms related to antibiotic use?

Authors:  J E McGowan
Journal:  Bull N Y Acad Med       Date:  1987-04

Review 6.  Bacterial resistance: exploring the facts and myths.

Authors:  B R Meyers
Journal:  Bull N Y Acad Med       Date:  1987-04

Review 7.  Trimethoprim resistance.

Authors:  P Huovinen
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

8.  Beta-lactam resistance in normal faecal flora from South Africa.

Authors:  P M Shanahan; C J Thomson; S G Amyes
Journal:  Epidemiol Infect       Date:  1995-10       Impact factor: 2.451

9.  High frequency of antimicrobial resistance in human fecal flora.

Authors:  S B Levy; B Marshall; S Schluederberg; D Rowse; J Davis
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

10.  Comparative activity of the new fluoroquinolone rufloxacin (MF 934) against clinical isolates of gram-negative and gram-positive bacteria.

Authors:  S M Qadri; Y Ueno; G Postle; D Tullo; J San Pedro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-05       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.